Skip to main content

AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) Investor Securities Class Action Lawsuit 10/01/2014

  • If you purchased shares of AcelRx Pharmaceuticals Inc (NASDAQ: ACRX), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

January 18, 2016 - The case was dismissed. November 25, 2015 - The court granted the defendants' motion to dismiss. The plaintiffs were given leave to amend the complaint. June 2, 2015 - A motion to dismiss the amended complaint was filed. April 17, 2015 - An amended complaint was filed. (Update) March 16, 2015 - On March 9, 2015, AcelRx Pharmaceuticals Inc provided an update on the t...



You must register (for free) or login to view the entire case.